Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -7,638 | -1,570 | -3,827 | -10,248 |
| Depreciation Amortization | 106 | 65 | 23 | 25 |
| Accounts payable and accrued liabilities | 928 | 578 | 302 | N/A |
| Other Working Capital | 1,499 | 526 | 196 | -711 |
| Other Operating Activity | -7,510 | -7,293 | -93 | 1,392 |
| Operating Cash Flow | $-12,615 | $-7,694 | $-3,399 | $-9,542 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -551 | -494 | -449 | -266 |
| Investing Cash Flow | $-551 | $-494 | $-449 | $-266 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 5 | N/A | N/A | N/A |
| Other Financing Activity | 21,972 | 22,074 | 0 | 21,909 |
| Financing Cash Flow | $21,977 | $22,074 | $N/A | $21,909 |
| Beginning Cash Position | 18,104 | 18,104 | 18,104 | 6,003 |
| End Cash Position | 26,915 | 31,990 | 14,256 | 18,104 |
| Net Cash Flow | $8,811 | $13,886 | $-3,848 | $12,101 |
| Free Cash Flow | ||||
| Operating Cash Flow | -12,615 | -7,694 | -3,399 | -9,542 |
| Capital Expenditure | -551 | -494 | -449 | N/A |
| Free Cash Flow | -13,166 | -8,188 | -3,848 | -9,542 |